Eqis Capital Management, Inc. Vanda Pharmaceuticals Inc. Transaction History

Eqis Capital Management, Inc.

  • $1.21 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$15.69 - $21.14 $203,075 - $273,615
-12,943 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$15.35 - $21.27 $11,435 - $15,846
745 Added 6.11%
12,943 $222,000
Q2 2021

Aug 12, 2021
BUY
$15.71 - $21.51 $23,015 - $31,512
1,465 Added 13.65%
12,198 $262,000
Q1 2021

May 14, 2021
BUY
$13.42 - $20.28 $144,036 - $217,665
10,733 New
10,733 $161,000

Others Institutions Holding VNDA

# of Institutions
161
Shares Held
45.2M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $273M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Eqis Capital Management, Inc. Portfolio

Follow Eqis Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eqis Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email